SPECIFICITY, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SPECIFICITY, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $991.1K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.10M | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.18M | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $749.0K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $94.0K | Apr 15, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $469.1K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $468.4K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $548.3K | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | $416.9K | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $376.6K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $77.8K | Apr 15, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($473.1K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($615.3K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($1.07M) | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | ($3.78M) | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | ($2.38M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($75.5K) | Apr 15, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($305.3K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($505.7K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($774.3K) | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | ($3.73M) | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | ($2.33M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($75.5K) | Apr 15, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($89.8K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($361.9K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($603.7K) | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | ($2.00M) | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | ($1.11M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($54.2K) | Apr 15, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $10.3K | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $21.1K | Mar 30, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.56M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.56M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $89.1K | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | $160.6K | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $715.1K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $288.1K | Apr 15, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.14M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.18M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.98M | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.41M | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $1.09M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $51.0K | Apr 15, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($588.3K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($619.8K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($1.89M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($1.25M) | Jun 24, 2025 |
| FY2023 | Dec 31, 2021 | ($455.8K) | Mar 3, 2025 |
| FY2022 | Dec 31, 2020 | $237.0K | Mar 30, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.56M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($8.08M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($7.47M) | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | ($6.40M) | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | ($2.46M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($75.5K) | Apr 15, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.8K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.4K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $49.1K | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | $22.8K | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $637.8K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $217.1K | Apr 15, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 3, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 3, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.31M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 13.54M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 11.22M | Jun 24, 2025 |
| FY2023 | Dec 31, 2022 | 10.34M | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | 8.65M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 7.67M | Apr 15, 2022 |